» Articles » PMID: 32291282

Hybrid Insulin Peptides Are Recognized by Human T Cells in the Context of DRB1*04:01

Overview
Journal Diabetes
Specialty Endocrinology
Date 2020 Apr 16
PMID 32291282
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

T cells isolated from the pancreatic infiltrates of nonobese diabetic mice have been shown to recognize epitopes formed by the covalent cross-linking of proinsulin and secretory granule peptides. Formation of such hybrid insulin peptides (HIPs) was confirmed through mass spectrometry, and responses to HIPs were observed among the islet-infiltrating T cells of pancreatic organ donors and in the peripheral blood of individuals with type 1 diabetes (T1D). However, questions remain about the prevalence of HIP-specific T cells in humans, the sequences they recognize, and their role in disease. We identified six novel HIPs that are recognized in the context of DRB1*04:01, discovered by using a library of theoretical HIP sequences derived from insulin fragments covalently linked to one another or to fragments of secretory granule proteins or other islet-derived proteins. We demonstrate that T cells that recognize these HIPs are detectable in the peripheral blood of subjects with T1D and exhibit an effector memory phenotype. HIP-reactive T-cell clones produced Th1-associated cytokines and proliferated in response to human islet preparations. These results support the relevance of HIPs in human disease, further establishing a novel posttranslational modification that may contribute to the loss of peripheral tolerance in T1D.

Citing Articles

Immunopeptidomics for autoimmunity: unlocking the chamber of immune secrets.

Arshad S, Cameron B, Joglekar A NPJ Syst Biol Appl. 2025; 11(1):10.

PMID: 39833247 PMC: 11747513. DOI: 10.1038/s41540-024-00482-x.


Proinsulin C-peptide is a major source of HLA-DQ8 restricted hybrid insulin peptides recognized by human islet-infiltrating CD4 T cells.

Bhattacharjee P, Pakusch M, Lacorcia M, Tresoldi E, Rubin A, Foster A PNAS Nexus. 2024; 3(11):pgae491.

PMID: 39554513 PMC: 11565411. DOI: 10.1093/pnasnexus/pgae491.


Fifty years of HLA-associated type 1 diabetes risk: history, current knowledge, and future directions.

Noble J Front Immunol. 2024; 15:1457213.

PMID: 39328411 PMC: 11424550. DOI: 10.3389/fimmu.2024.1457213.


Antigen-specific T cell responses in autoimmune diabetes.

Dwyer A, Shaheen Z, Fife B Front Immunol. 2024; 15:1440045.

PMID: 39211046 PMC: 11358097. DOI: 10.3389/fimmu.2024.1440045.


Mapping of a hybrid insulin peptide in the inflamed islet β-cells from NOD mice.

Wenzlau J, Peterson O, Vomund A, DiLisio J, Hohenstein A, Haskins K Front Immunol. 2024; 15:1348131.

PMID: 38455055 PMC: 10917911. DOI: 10.3389/fimmu.2024.1348131.


References
1.
Wiles T, Delong T, Baker R, Bradley B, Barbour G, Powell R . An insulin-IAPP hybrid peptide is an endogenous antigen for CD4 T cells in the non-obese diabetic mouse. J Autoimmun. 2016; 78:11-18. PMC: 5337175. DOI: 10.1016/j.jaut.2016.10.007. View

2.
Ito Y, Ashenberg O, Pyrdol J, Luoma A, Rozenblatt-Rosen O, Hofree M . Rapid CLIP dissociation from MHC II promotes an unusual antigen presentation pathway in autoimmunity. J Exp Med. 2018; 215(10):2617-2635. PMC: 6170167. DOI: 10.1084/jem.20180300. View

3.
Kwok W, Roti M, DeLong J, Tan V, Wambre E, James E . Direct ex vivo analysis of allergen-specific CD4+ T cells. J Allergy Clin Immunol. 2010; 125(6):1407-1409.e1. PMC: 3909500. DOI: 10.1016/j.jaci.2010.03.037. View

4.
McGinty J, Marre M, Bajzik V, Piganelli J, James E . T cell epitopes and post-translationally modified epitopes in type 1 diabetes. Curr Diab Rep. 2015; 15(11):90. PMC: 4902156. DOI: 10.1007/s11892-015-0657-7. View

5.
van Lummel M, Duinkerken G, Van Veelen P, de Ru A, Cordfunke R, Zaldumbide A . Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes. Diabetes. 2013; 63(1):237-47. DOI: 10.2337/db12-1214. View